Viloxazine?

Viloxazine is a non-stimulant prescription medication used for ADHD. It’s sold as an extended-release capsule under the brand name Qelbree.

Key points:
- Mechanism: It acts mainly as a norepinephrine reuptake inhibitor (NRI) with additional effects on other neurotransmitters. It is not a stimulant like methylphenidate or amphetamines.
- Indication: FDA-approved for ADHD in children and adolescents (roughly ages 6–17). It has been studied for adults, but you should check the current labeling or with a clinician for adult use.
- Dosing: Given as extended-release capsules taken once daily with or without food. The dose is individualized and usually started low and gradually increased over weeks under a clinician’s supervision. In pediatric labeling, the typical range covers up to about 400 mg per day; exact dosing and maximums depend on age and the official label.
- Onset and effectiveness: Like other non-stimulants, improvement may take several weeks. Benefits are typically gradual.
- Common side effects: Sleepiness or fatigue, decreased appetite, nausea or stomach upset, irritability, and dizziness. Less commonly, insomnia, weight changes, or mood changes can occur.
- Safety and interactions: Avoid use with monoamine oxidase inhibitors (MAOIs) or within a certain window around MAOIs. Can raise heart rate or blood pressure in some people; monitor blood pressure and heart rate as advised by your clinician. Tell your provider about all medicines you take to check for interactions.
- Pregnancy/breastfeeding: Discuss with a clinician if you’re pregnant, planning pregnancy, or breastfeeding.
- Availability: Prescription only. Not a controlled substance.

If you have a specific question—such as dosing for a particular age, potential drug interactions with meds you’re taking, or safety concerns—tell me and I’ll tailor the info. Also, if you’re considering viloxazine for ADHD or any other condition, it’s best to discuss with a healthcare professional who can review your medical history and options.